FDA Inspection 987775 — New Jersey Laboratories

New Jersey Laboratories — FEI 2219935

The FDA completed an inspection of New Jersey Laboratories on Sep 23, 2016 in New Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 23, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Brunswick, NJ (United States)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
189021 CFR 211.165(e)Test methods
202721 CFR 211.192Investigations of discrepancies, failures
361321 CFR 211.160(b)(4)Establishment of calibration procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.